ActnerLab

Procagen is a genetic analysis service company based in Seongnam-si, South Korea, specializing in the prediction of prostate cancer risk. By leveraging genetic biomarkers and advanced artificial intelligence, the company analyzes clinical, genomic, and imaging data to develop algorithms that assess the risk of prostate cancer. Procagen offers a quantitative risk score that helps identify potential patients at risk for the disease. In addition to risk assessment, the company provides genetic counseling and personalized prevention and screening plans aimed at early diagnosis and management of prostate cancer and related urinary diseases. Through its innovative approach, Procagen aims to enhance disease prediction and improve patient outcomes.

DC Medical Inc. is a medical device company based in Seoul, South Korea, founded in 2018. The company specializes in the development and commercialization of innovative medical devices aimed at enhancing patient care and improving quality of life. Its product offerings include Everybaby, a pregnancy diagnostic kit designed to identify the risk of premature birth, and a polypropylene mesh that is used for treating stress urinary incontinence, pelvic organ prolapse, and hernia surgery. DC Medical employs a unique No Research Develop Only (NRDO) business model, positioning itself as a pioneer in the South Korean medical device industry. Through its focus on advanced technology and patient-centered solutions, DC Medical aims to contribute to the improvement of healthcare standards and human dignity.

CARBOEXPERT INC. is a South Korean company based in Daejeon, established in 2015. It specializes in the production and supply of functional carbohydrates and standard reference materials, primarily for the carbohydrate research field. The company's product offerings include Maltooligosaccharide, Cyclodextrin, Glucoside, and Polysaccharides. These products cater to various industries, including research, medicine, food, and cosmetics, and are available for purchase online. CARBOEXPERT's commitment to providing high-quality materials supports advancements in carbohydrate research and applications across multiple sectors.

Gosohage Inc. is a legal technology company headquartered in Seoul, South Korea. It specializes in offering innovative legal platform services that leverage technology to enhance legal processes and accessibility. By focusing on law-tech solutions, Gosohage aims to streamline legal services, making them more efficient for users. The company's offerings are designed to meet the evolving needs of the legal industry, positioning it as a key player in the intersection of law and technology.

J.R. Labs Inc. is a global biotechnology healthcare company based in Daejeon, South Korea, specializing in the production of recombinant proteins for medical applications. The company utilizes advanced technology to control specific gene expression and cellular metabolism through non-coding RNA (ncRNA). J.R. Labs develops molecular therapeutics that target oncogenic ncRNAs, as well as RNA vaccines designed to combat multidrug-resistant pathogenic bacteria and various cancers. Its products are available for purchase online, reflecting its commitment to providing innovative healthcare solutions.

Y-IN is a South Korea-based company that provides biocompatible and ultra-thin polymer coatings for medical devices and implants. It specializes in polymer materials development and chemical vapor deposition polymerization processing to enhance device performance, offering protective coatings and deposition equipment that apply thin, uniform films with electrical insulation, moisture resistance, and chemical barrier properties. The firm serves medical device manufacturing as well as adjacent industries such as consumer electronics and automotive components, aiming to extend product durability and safeguard sensitive parts under demanding operating conditions.

D Emptyspace is a mobile application developed by DIFT Corp., which was founded in 2015 and is based in Seoul, South Korea. The application allows users to create immersive virtual galleries where they can customize their exhibition spaces using various templates. Users have the ability to invite friends and connect with other creators, fostering relationships among artists, critics, and collectors. D Emptyspace provides a platform for artists to curate their own spaces, share their stories, and present their work in a personalized manner. Additionally, the app facilitates the discovery of new and emerging artists, enhancing the overall experience of exploring and appreciating art in a virtual environment.

Benedea Inc. is a technology company based in Seoul, South Korea, founded in 2014. The company specializes in developing Han, a mobile input software that allows users to type simplified Chinese characters efficiently. This innovative software eliminates the need for users to convert pronunciations from the Roman alphabet into Chinese characters. In addition to its focus on Chinese input, Benedea also develops software for typing Japanese kanji, catering to the needs of users who require efficient input methods for both languages.

Kozaza Inc. is a home sharing platform based in Seoul, South Korea, specializing in a variety of unique and affordable accommodations, including homestays, apartments, guesthouses, and traditional Korean houses known as Hanoks. The name "Kozaza" reflects its mission to provide a restful experience, translating to "sleep well as baby" in Korean. Since its designation as a sharing company by the Seoul Metropolitan Government in 2013, Kozaza has partnered with local governments to promote a new culture of accommodation for foreign visitors. The platform emphasizes local service and cost-effectiveness, offering lower service fees and special promotions with local hosts. Kozaza aims to enhance the travel experience in Korea by providing diverse lodging options tailored to various preferences.

Founded in 2015, Retrofit Korea specializes in providing engineering services for retrofitting ships, offshore plants, and industrial facilities. The company offers Ballast Water Treatment System installation, reverse engineering, and consulting services, utilizing advanced technologies like 3D laser scanning to generate accurate As-Is data.

Tecozyme Inc, based in Seoul, South Korea, specializes in developing innovative dental products designed to maintain a healthy oral ecosystem. Its portfolio includes self-cleaning dental implants, a photodynamic dental plaque removal healing abutment, zinc-based oral care products like Zinc Vita 21, and bad breath removal patches. These products aim to promote oral health by targeting bacteria, inflammation, and other oral disease-causing factors.

Ballop is a local brand specializing in a diverse range of sports footwear and apparel, with a particular focus on aqua shoes for the Korean market. The company provides a variety of products, including shoes and clothing designed for different sports and seasonal conditions, as well as accessories tailored for water sports. By offering quality sports clothing suitable for all four seasons, Ballop aims to meet the needs of active consumers seeking functional and stylish athletic wear.

Founded in Seoul, South Korea in 2016, Roborus specializes in AI-driven smart ordering solutions. Using facial recognition and advanced AI technology, their SaaS platform identifies customers, enhances ordering experiences, saves time for businesses, increases profits, and provides customer insights.

G+FLAS Life Sciences is an agricultural biotechnology company focused on genome editing technologies for crops and health-related applications. It develops glycoengineered plants using CRISPR-PLUS to selectively remove glycosylation-related genes and provides gene-editing delivery methods into plant protoplasts. The company also pursues development of novel seeds and gene therapy drugs based on CRISPR-Cas, and operates plant cultivation facilities to support pharmaceutical and anticancer R&D. In addition to crop improvements, G+FLAS has explored nutritionally enhanced foods, including vitamin D3-enriched tomatoes, and has pursued strategic partnerships to scale commercialization, such as collaborations with large industry players to enable broader adoption of its technology. Through its integrated approach spanning plant biotechnology and therapeutic research, G+FLAS Life Sciences aims to advance sustainable agriculture and novel drug development.

EOFlow Co., Ltd. is a South Korean company specializing in drug delivery solutions, particularly in the development of wearable insulin pumps. Its flagship product, EOPatch, is recognized as the world's smallest full-featured disposable insulin pump, designed to be smarter, better-connected, and longer-lasting than competing devices, all while being more cost-effective. The company plans to enhance EOPatch with a software upgrade that will enable closed-loop insulin control, effectively functioning as an automated insulin delivery system or "artificial pancreas." Additionally, EOFlow is working on an all-in-one wearable disposable artificial pancreas solution, which has received Breakthrough Device designation from the FDA, highlighting its potential impact on diabetes management.

NAiEEL Technology is a manufacturer specializing in boron nitride nanotubes and carbon nanotubes, catering to diverse industries such as information technology, nuclear, space, energy, and biomedicine. Founded in 2015 and headquartered in Daejeon, South Korea, with an additional office in Stony Brook, New York, the company produces white boron nitride nanotube powder in varying purities through a thermo-chemical reaction process. Its products serve multiple applications, including electric insulation, thermal conducting materials, high-temperature structural components, desalination membranes, and BNCT drug target applications. By providing advanced materials, NAiEEL Technology aims to enhance the reliability and efficiency of energy and environmental technologies.

Femtobiomed Inc. is a South Korea-based company specializing in the development of a cargo-free intracellular delivery platform known as CELLSHOT. This innovative platform facilitates advancements in cell-based therapeutics and supports research in cell biology. Femtobiomed's core focus is on creating effective anti-cancer treatment drugs, leveraging its technology to enhance therapeutic outcomes. The company's work represents a significant step forward in the field of cell therapeutics, aiming to provide novel solutions for cancer treatment and improve the efficacy of existing therapies.